Literature DB >> 6994983

Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers.

S Dawling, P Crome, R Braithwaite.   

Abstract

A single oral dose of 75mg nortriptyline was given to a group of 20 depressed elderly patients in hospital. Subsequent plasma nortriptyline concentrations were used to calculate the half-life and clearance of the drug. These measurements were compared with those made previously in 17 healthy young volunteer subjects. Plasma nortriptyline half-life was longer and clearance slower (p < 0.002) in the elderly group than in the volunteers. There was no correlation of age with either of these parameters within the 2 groups, and no differences in nortriptyline pharmacokinetics could be detected between the male and female volunteer subjects. The possible reasons for these findings and their clinical consequences are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994983     DOI: 10.2165/00003088-198005040-00007

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  24 in total

1.  Proceedings: Presystemic hepatic elimination.

Authors:  G R Wilkinson; D G Shand
Journal:  Acta Pharm Suec       Date:  1974-12

2.  The radioimmunoassay of tricyclic antidepressants.

Authors:  G W Aherne; E M Piall; V Marks
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

Review 3.  Drug use in the elderly: a review of problems and special considerations.

Authors:  R E Vestal
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

4.  Plasma nortriptyline levels--relationship to clinical effects.

Authors:  M Asberg
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

5.  Nortriptyline in depressed patients with high plasma levels. II.

Authors:  R Braithwaite; S Montgomery; S Dawling
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

6.  Correlation between plasma levels of nortriptyline and clinical effects.

Authors:  P Kragh-Sørensen
Journal:  Commun Psychopharmacol       Date:  1978

7.  Nortriptyline therapy in elderly patients: dosage prediction after single dose pharmacokinetic study.

Authors:  S Dawling; P Crome; R A Braithwaite; R R Lewis
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953

8.  Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression.

Authors:  P Kragh-Sorensen; C E Hansen; P C Baastrup; E F Hvidberg
Journal:  Psychopharmacologia       Date:  1976-02-02

9.  Predisposing factors in adverse reactions to drugs.

Authors:  N Hurwitz
Journal:  Br Med J       Date:  1969-03-01

10.  Effect of activated charcoal on absorption of nortriptyline.

Authors:  P Crome; S Dawling; R A Braithwaite; J Masters; R Walkey
Journal:  Lancet       Date:  1977-12-10       Impact factor: 79.321

View more
  10 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 2.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  Population pharmacokinetics and pharmacodynamics: potential use for gathering dose-concentration-response.

Authors:  M Jerling
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

4.  The pharmacokinetics of nortriptyline in patients with chronic renal failure.

Authors:  S Dawlilng; K Lynn; R Rosser; R Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

5.  Clinical pharmacokinetics of dothiepin. Single-dose kinetics in patients and prediction of steady-state concentrations.

Authors:  K P Maguire; T R Norman; I McIntyre; G D Burrows
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

6.  The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.

Authors:  J E Burch
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method.

Authors:  M Jerling; Y Merlé; F Mentré; A Mallet
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications.

Authors:  L L von Moltke; D J Greenblatt; R I Shader
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

Review 9.  Pharmacokinetics of antidepressants in patients with hepatic impairment.

Authors:  Massimo Carlo Mauri; Alessio Fiorentini; Silvia Paletta; Alfredo Carlo Altamura
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

Review 10.  Free drug metabolic clearance in elderly people.

Authors:  Jennifer M Butler; Evan J Begg
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.